ICU sedation, delirium & recovery

Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities

Intensive Care MedPublished Narrative review with recommendations

Recommendations

As issued by the authors

  1. Recommendations for diagnosis, management and treatment of cytokine release syndrome, immune effector cell associated neurotoxicity syndrome, hematotoxicity, hypogammaglobulinemia and CAR-T cell-induced pseudo-progression, among others

Original publication

Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities. Intensive Care Med. Published 22 August 2024. doi:10.1007/s00134-024-07576-4

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.